ProteinLogic

ProteinLogic is a biomarker discovery and development company that is developing a novel diagnostic platform and diagnostic products to address unmet critical medical needs in infectious and inflammatory diseases. The proprietary biomarker technology (ImmiPrint®) developed by the company has the potential for early diagnosis and prediction of disease onset, and provides information on how diseases progress and respond to specific drug treatments.